Karol Bukowski
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Synthesis and Characterization of Heterocyclic Compounds 7
- Quinazolinone synthesis and applications 4
- Synthesis and biological activity 4
- Synthesis and Biological Evaluation 2
-
- DNA Repair Mechanisms 2
- Cancer therapeutics and mechanisms 2
- Co-authors
- Mateusz Kciuk (8 shared papers)Renata Kontek (8 shared papers)Katarzyna Woźniak (3 shared papers)Beata Marciniak (7 shared papers)Katarzyna Mokra (2 shared papers)Mariusz Mojzych (5 shared papers)Somdutt Mujwar (5 shared papers)Daniel Wysokiński (1 shared paper)
In The Last Decade
Karol Bukowski
16 papers receiving 1.4k citations
Karol Bukowski's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 219
- Biomaterials 191
- Oncology 357
- Drug Discovery 2
- Toxicology 33
Countries citing papers authored by Karol Bukowski
This map shows the geographic impact of Karol Bukowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karol Bukowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karol Bukowski more than expected).
Fields of papers citing papers by Karol Bukowski
This network shows the impact of papers produced by Karol Bukowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karol Bukowski. The network helps show where Karol Bukowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Karol Bukowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of Multidrug Resistance in Cancer Chemotherapy Hit paper breakdown → | 2020 | 1265 |
| 2 | 2022 | 28 | |
| 3 | 2019 | 20 | |
| 4 | 2018 | 15 | |
| 5 | 2020 | 15 | |
| 6 | 2023 | 9 | |
| 7 | 2022 | 9 | |
| 8 | 2025 | 7 | |
| 9 | 2024 | 7 | |
| 10 | 2017 | 7 | |
| 11 | 2023 | 6 | |
| 12 | 2025 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2025 | 1 |
About Karol Bukowski
Karol Bukowski is a scholar working on Organic Chemistry, Molecular Biology, Cancer Research, Health, Toxicology and Mutagenesis and Oncology, having authored 16 papers that have together received 1.4k indexed citations. Recurring topics across this work include Synthesis and Characterization of Heterocyclic Compounds (7 papers), Quinazolinone synthesis and applications (4 papers), Synthesis and biological activity (4 papers), DNA Repair Mechanisms (2 papers), Cancer therapeutics and mechanisms (2 papers), Pesticide Exposure and Toxicity (2 papers), Synthesis and Biological Evaluation (2 papers) and Toxic Organic Pollutants Impact (2 papers). The work is most often cited by research in Cancer Research (219 citations), Biomaterials (191 citations), Oncology (357 citations), Drug Discovery (2 citations) and Toxicology (33 citations). Karol Bukowski has collaborated with scholars based in Poland, India and Türkiye. Frequent co-authors include Mateusz Kciuk, Renata Kontek, Katarzyna Woźniak, Beata Marciniak, Katarzyna Mokra, Mariusz Mojzych, Somdutt Mujwar, Daniel Wysokiński, Anna Szymanowska and Agnieszka Marczak. Their work appears in journals such as International Journal of Molecular Sciences, Human & Experimental Toxicology, Cancers, Molecules and Beilstein Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.